This course provides survey of the leading non-infectious and non-cancerous
diseases in the industrialized world. This course will explore the molecular
mechanisms of disease, clinical symptomology, and pharmacological treatment.
Students will be expected to conduct thorough research on a given disease
and present their results in a poster session.
Prerequisites: BIO 306, 313 and CHM 300 or 304. Lect. 3. Offered Sem.
II.
Instructors: Aaron Monte, Room 4020 Cowley
Hall, 785-8263, monte@mail.uwlax.edu
Scott Cooper, Room 3022 Cowley Hall, 785-6983, cooper@mail.uwlax.edu
Guest lecturers from Gundersen Lutheran Medical Center and UWL will present
some of the clinical lectures.
Lectures: MWF from
8:50-9:45 in room 301 Cowley Hall. You are responsible for all material
covered in class,
homework assigned, and any changes announced in exam dates.
Textbook: The text is meant to serve as a resource, some lectures may not follow the textbook very closely.
Essential Pathology. Second Edition. By Rubin and Farber
Exams:
(300 points) There will be three scheduled exams [100 points
each].
Poster Presentation: (100 points) Each student
will present a poster on an assigned disease. If you have a specific
disease that you would like to research, and that we dont cover in depth
in lecture see me for permission.
The posters will be divided into four groups and each group will be presented
on a different day.
The material on the posters will be fair game on the final exam.
Posters will be graded by the instructor
and by four students. Abstracts for the posters will be due two weeks
before the first poster session
and will be distributed to each student.
Final Exam: (200 points) There will be a comprehensive
final exam covering all lectures and assigned readings.
This course will count as an elective for students in the Cellular and
Molecular Biology Concentration
and the Biomedical Science Concentration.
Syllabus
Week Topic Guest Speaker
1
Cell injury
A. Inflammation
B. Repair and regeneration
C. Immune response
2
Intro to Pharmacology
A. Overview of drug action
B. Molecular targets
C. Pharmacodynamics
D. Pharmacokinetics
3
Autoimmune diseases and anemias
Wayne Bottner
A. Rheumatoid arthritis
B. Lupus
C. Anemias
EXAM 1
4
Hemodynamic disorders
John Farnen
A. Hemostasis and Thrombosis
B. Clotting and bleeding disorders
C. Stroke
5
Heart Disease
Ward Brown
A. Atherosclerosis
B. Familial Hypercholesterolemia
C. Myocardial Infarction
6
Respiratory Disease
Todd Mahr
A. Emphysema
B. Bronchitis
C. Asthma
D. Cystic Fibrosis
7
Metabolic Disease
Peggy Maher
A. Diabetes
B. Obesity
EXAM 2
8
Neurouscular Diseases
A. Muscular dystrophy
B. Epilepsy
C. Multiple Sclerosis
9
Neuromuscular Diseases
A. Alzheimer Disease
B. Huntington Disease
C. Parkinson Disease
10
Psychiatric Illnesses
A. Depression
B. Schizophrenia
C. Anxiety
11
EXAM 3
Poster Sessions
12 Poster Sessions
13 Genetic Testing and Drug Development
14
Developmental and genetic diseases
Marc Williams
A. Metabolic diseases
B. Developmental diseases
C. Genetic counseling
Kevin Josephson
Copyright © 1998 , the University of Wisconsin-La Crosse and the Board of Regents of the University of Wisconsin.
If you have any questions about or additions to these pages please contact Tom Volk, volk_tj@mail.uwlax.edu